Kim H et al. |
In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists. |
2016 Sep-Oct |
Korean J Radiol |
pmid:27587950
|
Choi C et al. |
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. |
2016 |
J. Clin. Oncol. |
pmid:28248126
|
Burr SP et al. |
Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. |
2016 |
Cell Metab. |
pmid:27923773
|
Becker-Kettern J et al. |
Saccharomyces cerevisiae Forms D-2-Hydroxyglutarate and Couples Its Degradation to D-Lactate Formation via a Cytosolic Transhydrogenase. |
2016 |
J. Biol. Chem. |
pmid:26774271
|
Flavahan WA et al. |
Insulator dysfunction and oncogene activation in IDH mutant gliomas. |
2016 |
Nature |
pmid:26700815
|
de la Fuente MI et al. |
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. |
2016 |
Neuro-oncology |
pmid:26691210
|
Emir UE et al. |
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations. |
2016 |
Cancer Res. |
pmid:26669865
|
Liesenfeld DB et al. |
Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. |
2016 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:26585118
|
Andronesi OC et al. |
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. |
2016 |
Clin. Cancer Res. |
pmid:26534967
|
Waitkus MS et al. |
Isocitrate dehydrogenase mutations in gliomas. |
2016 |
Neuro-oncology |
pmid:26188014
|